Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
Mallinckrodt
McKesson
Harvard Business School

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Galactose


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Galactose?

Galactose is an investigational drug.

There have been 25 clinical trials for Galactose. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Syndrome, Mucopolysaccharidosis IV, and Mucopolysaccharidoses. The leading clinical trial sponsors are BioMarin Pharmaceutical, University of Aarhus, and Applied Therapeutics, Inc.

There are four hundred and forty-nine US patents protecting this investigational drug and twenty-three international patents.

Recent Clinical Trials for Galactose
TitleSponsorPhase
Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic GalactosemiaApplied Therapeutics, Inc.Phase 2/Phase 3
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human <=-Galactosidase in Type II GM1 GangliosidosisAxovant Sciences, Inc.Phase 1/Phase 2
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human <=-Galactosidase in Type II GM1 GangliosidosisNational Human Genome Research Institute (NHGRI)Phase 1/Phase 2

See all Galactose clinical trials

Clinical Trial Summary for Galactose

Top disease conditions for Galactose
Top clinical trial sponsors for Galactose

See all Galactose clinical trials

US Patents for Galactose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Galactose ⤷  Sign up for a Free Trial Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA) ⤷  Sign up for a Free Trial
Galactose ⤷  Sign up for a Free Trial Ophthalmic emulsion Alcon Research, Ltd. (Ft. Worth, TX) ⤷  Sign up for a Free Trial
Galactose ⤷  Sign up for a Free Trial Peptide pharmaceuticals EUMEDERIS PHARMACEUTICALS, INC. (San Diego, CA) ⤷  Sign up for a Free Trial
Galactose ⤷  Sign up for a Free Trial Recombinant microalgae including keto-acyl ACP synthase Corbion Biotech, Inc. (South San Francisco, CA) ⤷  Sign up for a Free Trial
Galactose ⤷  Sign up for a Free Trial Dual molecular delivery of oligonucleotides and peptide containing conjugates Merck Sharp & Dohme Corp. (Rahway, NJ) ⤷  Sign up for a Free Trial
Galactose ⤷  Sign up for a Free Trial Peptide pharmaceuticals EUMEDERIS PHARMACEUTICALS, INC. (San Diego, CA) ⤷  Sign up for a Free Trial
Galactose ⤷  Sign up for a Free Trial TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) YALE UNIVERSITY (New Haven, CT) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Galactose

Drugname Country Document Number Estimated Expiration Related US Patent
Galactose Argentina AR104674 2035-04-21 ⤷  Sign up for a Free Trial
Galactose Australia AU2016252737 2035-04-21 ⤷  Sign up for a Free Trial
Galactose Brazil BR112017022715 2035-04-21 ⤷  Sign up for a Free Trial
Galactose Canada CA2999843 2035-04-21 ⤷  Sign up for a Free Trial
Galactose European Patent Office EP3285797 2035-04-21 ⤷  Sign up for a Free Trial
Galactose World Intellectual Property Organization (WIPO) WO2016172319 2035-04-21 ⤷  Sign up for a Free Trial
Galactose Australia AU2014261788 2033-04-29 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
Mallinckrodt
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.